Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes

Hanneke M.J. Nijland, Rovina Ruslami, Janneke E. Stalenhoef, Erni Juwita, Bachti Alisjahbana, Ron H.H. Nelwan, Andre J.A.M. Van Der Ven, Halim Danusantoso, Rob E. Aarnoutse, Reinout Van Crevel

Research output: Contribution to journalArticlepeer-review

162 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences